Use of interleukin-11 as therapeutic agent for heart disease
The present invention demonstrates the myocardial protective effects of interleukin 11 in vivo, and provides preventive, therapeutic, or other types of drugs for heart disease using interleukin 11 as the active ingredient. The present invention, by utilizing the myocardial protective effects of interleukin 11, can suppress the progress of myocardial injury, prevent the onset of heart failure, or suppress the progress of heart failure.
1. A method of treating heart disease, consisting of administering an effective amount of interleukin 11 (IL-11) and a carrier or vehicle to a patient in need thereof, wherein the heart disease is selected from the group consisting of myocardial remodeling after a myocardial injury and myocardial infarction, wherein the administration of the IL-11 regenerates myocardial tissue.
2. The method according to claim 1 , wherein the heart disease is myocardial remodeling after a myocardial injury.
3. The method according to claim 1 , wherein the heart disease is myocardial infarction.